Vesna Jaćević

Prof. Dr. Vesna Jaćević

Department for Experimental Toxicology and Pharmacology, National Poison Control Centre, Military Medical Academy
+2
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in Frontiers in Plant Science
Verified
Journal Article
Open access
PDF file
JDJelena Dumanović
Jelena Dumanović
ENEugenie Nepovimova
Eugenie Nepovimova
MNMaja Natić
Maja Natić
Kamil KucaKamil Kuca
Kamil Kuca
VJVesna Jaćević
Vesna Jaćević
In plants, there is a complex and multilevel network of the antioxidative system (AOS) operating to counteract harmful reactive species (RS), the foremost important of which are reactive oxygen species (ROS), and maintain homeostasis within the cell. Specific AOSs for plant cells are, first and foremost, enzymes of the glutathione-ascorbate cycle (Asc-GSH), followed by phenolic compounds and lipophilic antioxidants like carotenoids and tocopherols. Evidence that plant cells have excellent antioxidative defense systems is their ability to survive at H2O2concentrations incompatible with animal cell life. For the survival of stressed plants, it is of particular importance that AOS cooperate and participate in redox reactions, therefore, providing better protection and regeneration of the active reduced forms. Considering that plants abound in antioxidant compounds, and humans are not predisposed to synthesize the majority of them, new fields of research have emerged. Antioxidant potential of plant compounds has been exploited for anti-aging formulations preparation, food fortification and preservation but also in designing new therapies for diseases with oxidative stress implicated in etiology.

1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
QWQinghua Wu
Qinghua Wu
WWWenda Wu
Wenda Wu
VJVesna Jaćević
Vesna Jaćević
TFTanos C. C. Franca
Tanos C. C. Franca
Xu WangXu Wang
Xu Wang
Kamil KucaKamil Kuca
Kamil Kuca
C-Jun N-terminal kinase (JNK) signalling regulates both cancer cell apoptosis and survival. Emerging evidence show that JNK promoted tumour progression is involved in various cancers, that include human pancreatic-, lung-, and breast cancer. The pro-survival JNK oncoprotein functions in a cell context- and cell type-specific manner to affect signal pathways that modulate tumour initiation, proliferation, and migration. JNK is therefore considered a potential oncogenic target for cancer therapy. Currently, designing effective and specific JNK inhibitors is an active area in the cancer treatment. Some ATP-competitive inhibitors of JNK, such as SP600125 and AS601245, are widely used in vitro; however, this type of inhibitor lacks specificity as they indiscriminately inhibit phosphorylation of all JNK substrates. Moreover, JNK has at least three isoforms with different functions in cancer development and identifying specific selective inhibitors is crucial for the development of targeted therapy in cancer. Some selective inhibitors of JNK are identified; however, their clinical studies in cancer are relatively less conducted. In this review, we first summarised the function of JNK signalling in cancer progression; there is a focus on the discussion of the novel selective JNK inhibitors as potential targeting therapy in cancer. Finally, we have offered a future perspective of the selective JNK inhibitors in the context of cancer therapies. We hope this review will help to further understand the role of JNK in cancer progression and provide insight into the design of novel selective JNK inhibitors in cancer treatment.

1 July 2007 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
STSanja Trajković
Sanja Trajković
SDSilva Dobrić
Silva Dobrić
VJVesna Jaćević
Vesna Jaćević
VDViktorija Dragojević-Simić
Viktorija Dragojević-Simić
ZMZoran Milovanović
Zoran Milovanović
AĐAleksandar Đorđević
Aleksandar Đorđević

1 August 2013 in Toxicology Letters
Verified
Journal Article
Closed access
Aleksandra Buha ĐorđevićAleksandra Buha Đorđević
Aleksandra Buha Đorđević
BABiljana Antonijević
Biljana Antonijević
ZBZorica Bulat
Zorica Bulat
VJVesna Jaćević
Vesna Jaćević
VMVesna Milovanović
Vesna Milovanović
VMVesna Matović
Vesna Matović

31 July 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Danica JovićDanica Jović
Danica Jović
VJVesna Jaćević
Vesna Jaćević
Kamil KucaKamil Kuca
Kamil Kuca
IBIvana Djordjije Borišev
Ivana Djordjije Borišev
MMMrdanovic Mrdanovic
Mrdanovic Mrdanovic
Aleksandar DjordjevicAleksandar Djordjevic
Aleksandar Djordjevic
Being a member of the nanofamily, carbon nanomaterials exhibit specific properties that mostly arise from their small size. They have proved to be very promising for application in the technical and biomedical field. A wide spectrum of use implies the inevitable presence of carbon nanomaterials in the environment, thus potentially endangering their whole nature. Although scientists worldwide have conducted research investigating the impact of these materials, it is evident that there are still significant gaps concerning the knowledge of their mechanisms, as well as the prolonged and chronic exposure and effects. This manuscript summarizes the most prominent representatives of carbon nanomaterial groups, giving a brief review of their general physico-chemical properties, the most common use, and toxicity profiles. Toxicity was presented through genotoxicity and the activation of the cell signaling pathways, both including in vitro and in vivo models, mechanisms, and the consequential outcomes. Moreover, the acute toxicity of fullerenol, as one of the most commonly investigated members, was briefly presented in the final part of this review. Thinking small can greatly help us improve our lives, but also obliges us to deeply and comprehensively investigate all the possible consequences that could arise from our pure-hearted scientific ambitions and work.

18 May 2023 in Toxicology
Verified
Journal Article
Closed access
VJVesna Jaćević
Vesna Jaćević
JDJelena Dumanović
Jelena Dumanović
SASuliman Y. Alomar
Suliman Y. Alomar
RRRadmila Resanović
Radmila Resanović
ZMZoran Milovanović
Zoran Milovanović
KKKamil Kuča
Kamil Kuča